Study of the Safety and Effectiveness of BC1036 Capsules to Treat Frequent Long-Term Cough

Phase 3 Completed 288 enrolled Respicopea Limited

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the effect of BC1036 (theobromine) on cough-related quality of life and cough severity following 2 weeks' treatment.

Timeline

Start: 2012-07
Primary completion: 2013-08
Completion: 2013-08

Publications

Morice AH, McGarvey L, Pavord ID, Higgins B, Chung KF, Birring SS. Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial. J Thorac Dis. 2017 Jul;9(7):1864-1872. doi: 10.21037/jtd.2017.06.18.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Theobromine	Small molecule	300 mg	Oral

Indications

No indication recorded.